Rohto Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: FMCG
  • ISIN: JP3982400008
JPY
2,494.00
42 (1.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
81,964.00
82,730.00
86,813.00
70,726.00
68,356.00
69,677.00
73,294.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
81,964.00
82,730.00
86,813.00
70,726.00
68,356.00
69,677.00
73,294.00
Raw Material Cost
36,617.00
37,473.00
36,984.00
31,381.00
29,371.00
29,952.00
29,930.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
316.00
385.00
436.00
63.00
65.00
16.00
71.00
Selling and Distribution Expenses
30,334.00
35,469.00
31,946.00
28,891.00
23,733.00
29,899.00
26,310.00
Other Expenses
307.00
285.40
309.40
445.40
356.10
502.50
268.60
Total Expenditure (Excl Depreciation)
70,337.00
76,181.00
72,460.00
64,789.00
56,730.00
64,892.00
58,997.00
Operating Profit (PBDIT) excl Other Income
11627
6549
14353
5937
11626
4785
14297
Other Income
4,821.00
2,590.00
2,351.00
1,193.00
750.00
419.00
344.00
Operating Profit (PBDIT)
20,533.00
13,784.00
20,757.00
9,329.00
14,622.00
7,587.00
16,824.00
Interest
316.00
385.00
436.00
63.00
65.00
16.00
71.00
Exceptional Items
-1,058.00
-1,218.00
-49.00
-584.00
-217.00
-240.00
-542.00
Gross Profit (PBDT)
45,347.00
45,257.00
49,829.00
39,345.00
38,985.00
39,725.00
43,364.00
Depreciation
4,085.00
4,645.00
4,053.00
2,199.00
2,246.00
2,383.00
2,183.00
Profit Before Tax
15,074.00
7,536.00
16,219.00
6,482.00
12,094.00
4,948.00
14,026.00
Tax
3,021.00
1,196.00
4,417.00
2,157.00
3,609.00
84.00
4,320.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
11,769.00
6,200.00
11,885.00
4,437.00
8,483.00
4,779.00
9,563.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
11,769.00
6,200.00
11,885.00
4,437.00
8,483.00
4,779.00
9,563.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
283.00
140.00
-83.00
-112.00
1.00
85.00
143.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
12,052.00
6,340.00
11,802.00
4,325.00
8,484.00
4,864.00
9,706.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,66,743.00
2,60,095.00
2,56,071.00
2,53,042.00
2,57,786.00
2,46,326.00
2,40,039.00
Earnings per share (EPS)
51.39
27.02
51.95
19.39
37.08
20.89
41.8
Diluted Earnings per share
51.39
27.02
51.95
19.39
37.08
20.89
41.8
Operating Profit Margin (Excl OI)
14.19%
7.92%
16.53%
8.39%
17.01%
6.87%
19.51%
Gross Profit Margin
23.37%
14.72%
23.35%
12.27%
20.98%
10.52%
22.12%
PAT Margin
14.36%
7.49%
13.69%
6.27%
12.41%
6.86%
13.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -0.93% vs -4.70% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 90.09% vs -46.28% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 40.36% vs -39.18% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -17.92% vs -11.70% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Rohto Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
81,964.00
2,41,590.00
-1,59,626.00
-66.07%
Other Operating Income
0.00
0.00
0.00
Total Operating income
81,964.00
2,41,590.00
-1,59,626.00
-66.07%
Raw Material Cost
36,617.00
55,302.00
-18,685.00
-33.79%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
316.00
1,076.00
-760.00
-70.63%
Selling and Distribution Expenses
30,334.00
1,77,296.00
-1,46,962.00
-82.89%
Other Expenses
307.00
-107.60
414.60
385.32%
Total Expenditure (Excl Depreciation)
70,337.00
2,32,598.00
-1,62,261.00
-69.76%
Operating Profit (PBDIT) excl Other Income
11,627.00
8,992.00
2,635.00
29.30%
Other Income
4,821.00
3,758.00
1,063.00
28.29%
Operating Profit (PBDIT)
20,533.00
30,150.00
-9,617.00
-31.90%
Interest
316.00
1,076.00
-760.00
-70.63%
Exceptional Items
-1,058.00
0.00
-1,058.00
Gross Profit (PBDT)
45,347.00
1,86,288.00
-1,40,941.00
-75.66%
Depreciation
4,085.00
17,400.00
-13,315.00
-76.52%
Profit Before Tax
15,074.00
11,672.00
3,402.00
29.15%
Tax
3,021.00
6,463.00
-3,442.00
-53.26%
Provisions and contingencies
0
0
0.00
Profit After Tax
11,769.00
5,848.00
5,921.00
101.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
11,769.00
5,848.00
5,921.00
101.25%
Share in Profit of Associates
0
0
0.00
Minority Interest
283.00
-517.00
800.00
154.74%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
12,052.00
5,331.00
6,721.00
126.07%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,66,743.00
6,13,940.00
-3,47,197.00
-56.55%
Earnings per share (EPS)
51.39
14.63
36.76
251.26%
Diluted Earnings per share
51.39
14.63
36.76
251.26%
Operating Profit Margin (Excl OI)
14.19%
3.72%
0.00
10.47%
Gross Profit Margin
23.37%
12.03%
0.00
11.34%
PAT Margin
14.36%
2.42%
0.00
11.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 8,196.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -0.93% vs -4.70% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 19.91% vs 11.75% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1,205.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 90.09% vs -46.28% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 42.06% vs -8.30% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,571.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 40.36% vs -39.18% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 13.26% vs 2.38% in Jun 2024

Quarterly - Interest
Interest 31.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -17.92% vs -11.70% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 386.15% vs 41.30% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.19%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024